For DCM patients carrying a pathogenic LMNA gene mutation, considering the placement of an ICD for primary prevention is essential, particularly if the projected 5-year risk of encountering life-threatening VA is ≥10%. Here, LMNA is linked to familial dilated cardiomyopathy.